Sfoglia per AUTORE
PALUMBO A
Collezione AOU Città della Salute di Torino

  

Items : 90

Clinical parameters of death and heart failure hospitalization in biventricular systolic dysfunction assessed via cardiac magnetic resonance. in International journal of cardiology / Int J Cardiol. 2025 Jan 15;419:132709. doi: 10.1016/j.ijcard.2024.132709. Epub 2024 Nov 7.
2025
AOU Città della Salute di Torino

Sverzellati N; Squeri A; Schoepf UJ; Sbarbati S; Rodriguez-Palomares JF; Raineri C; Rabbat MG; Presicci C; Pradella S; Marra MP; Pedrotti P; Pavon AG; Palumbo A; Nese A; Mushtaq S; Muscogiuri G; Moro C; Masi A; Marzo F; Masci PG; Martini C; Margonato D; Lozano-Torres J; Lorenzoni V; Lanzillo C; Lombardi M; Gravina M; Guglielmo M; Gismondi A; et alii...

CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Dilated Left Ventricular Cardiomyopathy: a sub-study from the DERIVATE Registry. in European heart journal. Cardiovascular Imaging / Eur Heart J Cardiovasc Imaging. 2025 Feb 3:jeaf043. doi: 10.1093/ehjci/jeaf043.
2025
AOU Città della Salute di Torino

Leo I; Dellegrottaglie S; Scatteia A; Torella D; Abete R; Aquaro GD; Baggiano A; Barison A; Bogaert J; Calo' L; Camastra G; Carigi S; Carrabba N; Casavecchia G; Censi S; Cicala G; De Cecco CN; De Lazzari M; Di Giovine G; Dobrovie M; Focardi M; Fusini L; Gaibazzi N; Gismondi A; Gravina M; Guglielmo M; Lanzillo C; Lombardi M; Lorenzoni V; et alii...

Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy. in European heart journal. Cardiovascular Imaging / Eur Heart J Cardiovasc Imaging. 2023 Mar 21;24(4):472-482. doi: 10.1093/ehjci/jeac124.
2023
AOU Città della Salute di Torino

Al'Aref SJ; Altibi AM; Malkawi A; Mansour M; Baskaran L; Masri A; Rahmouni H; Abete R; Andreini D; Aquaro G; Barison A; Bogaert J; Camastra G; Carigi S; Carrabba N; Casavecchia G; Censi S; Cicala G; Conte E; De Cecco CN; De Lazzari M; Di Giovine G; Di Roma M; Dobrovie M; Focardi M; Gaibazzi N; Gismondi A; Gravina M; Guglielmo M; et alii...

2021
AOU Città della Salute di Torino

Einsele H; Palumbo A; Straka C; Corradini P; Wäsch R; Gentili S; Schub N; Spada S; Pönisch W; Aquino S; Patriarca F; Montefusco V; Salvini M; Engelhardt M; Offidani M; Günther A; Gay F; Boccadoro M; Sonneveld P; Gramatzki M;

2021
AOU Città della Salute di Torino

Zonder J; Boccadoro M; Thompson M; Weisel K; Berdeja J; Lee HC; Leleu X; Huang H; Stull DM; Cherepanov D; Terpos E; Hajek R; Romanus D; Palumbo A; Abonour R; Usmani S; Morgan G; Costello C; Rifkin R; Davies F; Cook G; Puig N; Vela-Ojeda J; Farrelly E; Raju A; Blazer M; Chari A;

CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international Registry. in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology / Europace. 2021 Jul 18;23(7):1072-1083. doi: 10.1093/europace/euaa401.
2021
AOU Città della Salute di Torino

Guaricci AI; Masci PG; Muscogiuri G; Guglielmo M; Baggiano A; Fusini L; Lorenzoni V; Martini C; Andreini D; Pavon AG; Aquaro GD; Barison A; Todiere G; Rabbat MG; Tat E; Raineri C; Valentini A; Varga-Szemes A; Schoepf UJ; De Cecco CN; Bogaert J; Dobrovie M; Symons R; Focardi M; Gismondi A; Lozano-Torres J; Rodriguez-Palomares JF; Lanzillo C; Di Roma M; et alii...

2021
AOU Città della Salute di Torino

Terpos E; Mikhael J; Hajek R; Chari A; Zweegman S; Lee HC; Mateos MV; Larocca A; Ramasamy K; Kaiser M; Cook G; Weisel KC; Costello CL; Elliott J; Palumbo A; Usmani SZ;

2021
AOU Città della Salute di Torino

Mina R; Bonello F; Petrucci MT; Liberati AM; Conticello C; Ballanti S; Musto P; Olivieri A; Benevolo G; Capra A; Gilestro M; Galieni P; Cavo M; Siniscalchi A; Palumbo A; Montefusco V; Gaidano G; Omedé P; Boccadoro M; Bringhen S;

Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study. in The Lancet. Haematology / Lancet Haematol. 2020 May;7(5):e395-e407. doi: 10.1016/S2352-3026(20)30044-2. Epub 2020 Mar 23.
2020
AOU Città della Salute di Torino

Anderson K; Nordström E; Chauhan D; Byrne C; Zubair H; Paba-Prada C; Reeves B; Mellqvist UH; Plesner T; Voorhees P; Bringhen S; Richardson PG; Harmenberg J; Palumbo A; Sonneveld P;

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial. in Haematologica / Haematologica. 2020 Jul;105(7):1937-1947. doi: 10.3324/haematol.2019.226407. Epub 2019 Oct 3.
2020
ASL Torino 4
AOU Città della Salute di Torino

Boccadoro M; Larocca A; Falco P; Hájek R; Palumbo A; Marasca R; Cellini C; Petrucci MT; Tosi P; Gentile M; Baldini L; Santoro A; Aquino S; Poggiu M; Pavone V; Gazzera G; De Rosa L; Grasso M; Rota-Scalabrini D; Pezzatti S; Spada S; Ballanti S; Pescosta N; Paris L; D'Agostino M; Bringhen S;

Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 Dec 1;38(34):4030-4041. doi: 10.1200/JCO.20.02060. Epub 2020 Oct 6.
2020
AOU Città della Salute di Torino

Labotka R; Vorog A; Morgan G; Mateos MV; Iida S; Leleu X; Katodritou E; Chng WJ; Beksac M; Bringhen S; Garg M; Hájek R; Oriol A; Quach H; Špi?ka I; Dimopoulos MA; Wang B; Palumbo A; Lonial S;

2020
AOU Città della Salute di Torino

Wester R; Zweegman S; van der Holt B; Kersten MJ; Vellenga E; van Marwijk-Kooy M; Asselbergs E; de Weerdt O; Minnema MC; Lonergan S; Palumbo A; Broijl A; Sonneveld P;

2020
AOU Città della Salute di Torino

Palumbo A; De Paoli L; Romano A; Zambello R; Falcone AP; Giuliani N; Paris L; Fraticelli V; Amico V; Musto P; Bernardini A; Cangiolosi C; Innao V; Oddolo D; Benevolo G; Spada S; Evangelista A; Patriarca F; Ledda A; Liberati AM; Offidani M; Mina R; Larocca A; Montefusco V; Hájek R; Boccadoro M; Bringhen S;

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis. in Cancers / Cancers (Basel). 2019 Nov 5;11(11):1735. doi: 10.3390/cancers11111735.
2019
AOU Città della Salute di Torino

Bonello F; Pulini S; Ballanti S; Gentile M; Spada S; Annibali O; Omedé P; Ronconi S; Cangialosi C; Podda L; Palmas A; Malfitano A; Rivoli G; Belotti A; Ciambelli F; Vincelli ID; Cafro AM; Innao V; Palumbo A; Sonneveld P; Spencer A; Hájek R; Boccadoro M; Gay F;

2019
AOU Città della Salute di Torino

Sonneveld P; Cavo M; Palumbo A; Rocci A; Liberati AM; Offidani M; Gamberi B; Troia R; Bernardini A; Conticello C; Larocca A; Grammatico S; Saraci E; Gilestro M; Muccio VE; Spada S; Omedé P; Gambella M; Boccadoro M; Oliva S; Gambella M; Omedé P; Spada S; Muccio VE; Gilestro M; Saraci E; Grammatico S; Larocca A; Conticello C; et alii...

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ria R; Boccadoro M; Vacca A; Dammacco F; Petrucci MT; Musto P; Montefusco V; Rizzo M; Falcone AP; Grasso M; Gottardi D; Leonardi G; Baldini L; Benevolo G; Callea V; Patriarca F; Guglielmelli T; Nozzoli C; Larocca A; Offidani M; De Paoli L; Martino E; Bringhen S; Palumbo A; Omedè P; Giuliani N; Saltarella I; Terragna C; Morabito F; et alii...

IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies. in Blood / Blood. 2019 Jan 10;133(2):156-167. doi: 10.1182/blood-2018-05-850826. Epub 2018 Nov 19.
2019
AOU Città della Salute di Torino

Deaglio S; Bertoni F; Rossi A; Riccio A; Audrito V; Cascione L; Todoerti K; Omedè P; Pullano V; Pellegrino E; Bandini C; Mereu E; Vitale N; Garaffo G; Riganti C; Bergaggio E; Neri A; Palumbo A; Piva R; Bergaggio E; Riganti C; Garaffo G; Vitale N; Mereu E; Bandini C; Pellegrino E; Pullano V; Omedè P; Todoerti K; et alii...

Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies. in Haematologica / Haematologica. 2019 Aug;104(8):1640-1647. doi: 10.3324/haematol.2018.208272. Epub 2019 Feb 7.
2019
AOU Città della Salute di Torino

Palumbo A; Di Raimondo F; Montefusco V; Di Toritto TC; Cavo M; Galieni P; Ponticelli E; Benevolo G; Spada S; Offidani M; Musto P; Ballanti S; Gaidano G; Petrucci MT; Mina R; Bringhen S; Boccadoro M; Larocca A;

Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Oct;130:27-35. doi: 10.1016/j.critrevonc.2018.07.003. Epub 2018 Jul 18.
2018
AOU Città della Salute di Torino

Bringhen S; Offidani M; Palmieri S; Pisani F; Rizzi R; Spada S; Evangelista A; Di Renzo N; Musto P; Marcatti M; Vallone R; Storti S; Bernardini A; Centurioni R; Aitini E; Palmas A; Annibali O; Angelucci E; Ferrando P; Baraldi A; Rocco S; Andriani A; Siniscalchi A; De Stefano V; Meneghini V; Palumbo A; Grammatico S; Boccadoro M; Larocca A; et alii...

2018
AOU Città della Salute di Torino

Efficace F; Boccadoro M; Palumbo A; Petrucci MT; Cottone F; Cannella L; Zamagni E; Niscola P; Kyriakou C; Caravita T; Offidani M; Mandelli F; Cavo M;

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2018 Jul;144(7):1357-1366. doi: 10.1007/s00432-018-2641-5. Epub 2018 Apr 19
2018
AOU Città della Salute di Torino
AOU Novara

Gay F; Petrucci MT; Boccadoro M; Offidani M; Palumbo A; Corradini P; Musto P; Tacchetti P; Nagler A; Benevolo G; Ria R; Caravita T; Cangialosi C; Marcatti M; Ponticelli E; Baldini L; Rocco S; Cascavilla N; Rizzi R; Angelucci E; Nozzoli C; Oddolo D; Ben-Yehuda D; Guglielmelli T; Mina R; Crippa C; Patriarca F; Spada S; De Paoli L; et alii...

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Dec;132:9-16. doi: 10.1016/j.critrevonc.2018.09.008. Epub 2018 Sep 14.
2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Gay F; Nagler A; Boccadoro M; Montefusco V; Palumbo A; Ribolla R; Siniscalchi A; Patriarca F; Pezzatti S; De Sabbata G; Di Renzo N; Rizzi R; Gamberi B; Baldini L; Guglielmelli T; Gilestro M; Catalano L; Marcatti M; Spada S; Petrucci MT; Ria R; Offidani M; De Paoli L; Conticello C; D'Agostino M;

Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2018 Aug;18(8):533-540. doi: 10.1016/j.clml.2018.05.019. Epub 2018 May 2
2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Bringhen S; Boccadoro M; Spencer A; Hájek R; Nagler A; Calafiore V; Falcone AP; Palumbo A; Benevolo G; Zambello R; Mannina D; Gamberi B; Baldini L; Guglielmelli T; Musto P; Malfitano A; Pescosta N; Ria R; De Paoli L; Cerrato C; Patriarca F; Spada S; Corradini P; Mina R; Petrucci MT; Mina R; Petrucci MT; Corradini P; Spada S; et alii...

Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study. in Leukemia / Leukemia. 2018 Aug;32(8):1803-1807. doi: 10.1038/s41375-018-0024-1. Epub 2018 Jan 30.
2018
AOU Città della Salute di Torino

Palumbo A; Lombardo A; Bertazzoni P; Rossi G; De Paoli L; Fanin R; Troia R; Patriarca F; Gaidano G; Belotti A; Spada S; Liberati AM; Cafro AM; Mina R; Bringhen S; Sonneveld P; Boccadoro M; Bringhen S; Mina R; Cafro AM; Liberati AM; Spada S; Belotti A; Gaidano G; Patriarca F; Troia R; Fanin R; De Paoli L; Rossi G; et alii...

Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma. in Leukemia / Leukemia. 2018 Apr;32(4):979-985. doi: 10.1038/leu.2017.327. Epub 2017 Nov 16.
2018
AOU Città della Salute di Torino
AOU Novara

Boccadoro M; Sonneveld P; Corradini P; Palumbo A; Gaidano G; Ballanti S; Petrucci MT; Offidani M; Musto P; De Angelis C; Esma F; Muccio VE; Liberati AM; Galieni P; Grammatico S; Montefusco V; De Paoli L; D'Agostino M; Bringhen S;

2017
AOU Città della Salute di Torino

Dimopoulos MA; Lonial S; White D; Moreau P; Palumbo A; San-Miguel J; Shpilberg O; Anderson K; Grosicki S; Spicka I; Walter-Croneck A; Magen H; Mateos MV; Belch A; Reece D; Beksac M; Bleickardt E; Poulart V; Sheng J; Sy O; Katz J; Singhal A; Richardson P;

Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. in Leukemia / Leukemia. 2017 Nov;31(11):2426-2434. doi: 10.1038/leu.2017.102. Epub 2017 Mar 27.
2017
AOU Città della Salute di Torino

Glavey SV; Naba A; Manier S; Clauser K; Tahri S; Park J; Reagan MR; Moschetta M; Mishima Y; Gambella M; Rocci A; Sacco A; O'Dwyer ME; Asara JM; Palumbo A; Roccaro AM; Hynes RO; Ghobrial IM; Glavey SV; Naba A; Manier S; Clauser K; Tahri S; Park J; Reagan MR; Moschetta M; Mishima Y; Gambella M; Rocci A; et alii...

2017
AOU Città della Salute di Torino

Gentile M; Magarotto V; Offidani M; Musto P; Bringhen S; Teresa Petrucci M; Gay F; Larocca A; Uccello G; Petrungaro A; Vigna E; Greco R; Grazia Recchia A; Tripepi G; Ria R; Di Raimondo F; Palumbo A; Morabito F;

Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma. in British journal of haematology / Br J Haematol. 2017 Mar;176(5):783-795. doi: 10.1111/bjh.14483. Epub 2016 Dec 22.
2017
AOU Città della Salute di Torino

Kaiser CJ; Conti I; Tai DF; Wooldridge JE; Kuliczkowski K; Beksac M; Huang SY; Oriol A; Holstein SA; Grz??ko N; Benboubker L; Terpos E; Raje NS; Moreau P; Nguyen TS; Cronier DM; Palumbo A;

Novel investigational drugs active as single agents in multiple myeloma. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2017 Jun;26(6):699-711. doi: 10.1080/13543784.2017.1324571. Epub 2017 Ma
2017
AOU Città della Salute di Torino

D'Agostino M; Salvini M; Palumbo A; Larocca A; Gay F;

Plasma cell leukemia: update on biology and therapy. in Leukemia & lymphoma / Leuk Lymphoma. 2017 Jul;58(7):1538-1547. doi: 10.1080/10428194.2016.1250263. Epub 2016 Nov 6.
2017
AOU Città della Salute di Torino

Palumbo A; Gay F; Cerrato C; D'Agostino M; Mina R;

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis. in Oncotarget / Oncotarget. 2017 Jan 24;8(4):5924-5935. doi: 10.18632/oncotarget.12641.
2017
AOU Città della Salute di Torino

Caravita T; Conticello C; Liberati AM; Pescosta N; Petrucci MT; Saraci E; Patriarca F; Genuardi M; Bernardini A; Pautasso C; Passera R; Ferrero S; Drandi D; Gay F; Muccio VE; Gilestro M; Gambella M; Oliva S; Rocci A; Musto P; Boccadoro M; Palumbo A; Omedè P;

Second primary malignancies in multiple myeloma: an overview and IMWG consensus. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Feb 1;28(2):228-245. doi: 10.1093/annonc/mdw606.
2017
AOU Città della Salute di Torino

Musto P; Anderson KC; Attal M; Richardson PG; Badros A; Hou J; Comenzo R; Du J; Durie BGM; San Miguel J; Einsele H; Chen WM; Garderet L; Pietrantuono G; Hillengass J; Kyle RA; Moreau P; Lahuerta JJ; Landgren O; Ludwig H; Larocca A; Mahindra A; Cavo M; Mazumder A; McCarthy PL; Nouel A; Rajkumar SV; Reiman A; Riva E; et alii...

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis. in Leukemia / Leukemia. 2017 Aug;31(8):1727-1734. doi: 10.1038/leu.2016.381. Epub 2016 Dec 23.
2017
AOU Città della Salute di Torino

Nagler A; Patriarca F; Caravita T; Falcone AP; Malfitano A; Cafro AM; Liberati AM; Troia R; Omedé P; Offidani M; Carella AM; Salvini M; Ria R; Campbell P; Spada S; Evangelista A; Catalano L; Musto P; Conticello C; Montefusco V; Petrucci MT; Oliva S; Gay F; Spencer A; Hajek R; Palumbo A; Boccadoro M;

Stem Cell Transplantation in Multiple Myeloma. in Current cancer drug targets / Curr Cancer Drug Targets. 2017;17(9):769-781. doi: 10.2174/1568009616666160920090236.
2017
AOU Città della Salute di Torino

Offidani M; Gentili S; Gay F; Aghemo E; Maracci L; Corvatta L; Palumbo A;

Optimizing Treatment for Elderly Patients With Newly Diagnosed Multiple Myeloma: A Personalized Approach. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2016 Oct 20;34(30):3600-3604. doi: 10.1200/JCO.2016.68.6113.
2016
AOU Città della Salute di Torino

Larocca A; Palumbo A;

Monoclonal antibodies for treating multiple myeloma - a new era, new safety considerations? in Expert opinion on drug safety / Expert Opin Drug Saf. 2016 Oct;15(10):1295-300. doi: 10.1080/14740338.2016.1201061. Epub 2016 Jul 5.
2016
AOU Città della Salute di Torino

Oliva S; Palumbo A;

International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2016 May 1;34(13):1544-57. doi: 10.1200/JCO.2015.65.0044. Epub 2016 Mar 14.
2016
AOU Città della Salute di Torino

Dimopoulos MA; Sonneveld P; Leung N; Merlini G; Ludwig H; Kastritis E; Goldschmidt H; Joshua D; Orlowski RZ; Powles R; Vesole DH; Garderet L; Einsele H; Palumbo A; Cavo M; Richardson PG; Moreau P; San Miguel J; Rajkumar SV; Durie BG; Terpos E;

Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma. in Leukemia / Leukemia. 2016 May;30(5):1211-4. doi: 10.1038/leu.2015.269. Epub 2015 Oct 6.
2016
AO Cuneo
AOU Città della Salute di Torino

Bruno B; Boccadoro M; Passera R; Giaccone L; Palumbo A; Omedè P; Fanin R; Boccasavia V; Brunello L; Ghione P; Ferrando F; Guarona G; Cena S; Benedetto R; Mordini N; Patriarca F; Festuccia M; Drandi D; Ferrero S; Ladetto M;

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma. in Blood / Blood. 2016 Mar 3;127(9):1102-8. doi: 10.1182/blood-2015-08-662627. Epub 2016 Jan 4.
2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Boccadoro M; Hajek R; Montefusco V; Guglielmelli T; Ledda A; Liberati AM; Ruggeri M; Zambello R; Maisnar V; Conticello C; Pulini S; Ciccone G; Bernardini A; Giuliani N; Musolino C; Gentili S; Pietrantuono G; Falcone AP; De Paoli L; Mina R; Patriarca F; Benevolo G; Offidani M; Bringhen S; Magarotto V;

Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers. in Journal of proteomics / J Proteomics. 2016 Mar 16;136:89-98. doi: 10.1016/j.jprot.2015.12.016. Epub 2016 Jan 13.
2016
AOU Città della Salute di Torino

Harshman SW; Canella A; Ciarlariello PD; Agarwal K; Branson OE; Rocci A; Cordero H; Phelps MA; Hade EM; Dubovsky JA; Palumbo A; Rosko A; Byrd JC; Hofmeister CC; Benson DM Jr; Paulaitis ME; Freitas MA; Pichiorri F;

2016
AOU Città della Salute di Torino

Terragna C; Remondini D; Martello M; Zamagni E; Pantani L; Patriarca F; Pezzi A; Levi G; Offidani M; Proserpio I; De Sabbata G; Tacchetti P; Cangialosi C; Ciambelli F; Viganò CV; Dico FA; Santacroce B; Borsi E; Brioli A; Marzocchi G; Castellani G; Martinelli G; Palumbo A; Cavo M;

The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective. in The oncologist / Oncologist. 2016 Mar;21(3):333-42. doi: 10.1634/theoncologist.2015-0303. Epub 2016 Feb 26.
2016
AOU Città della Salute di Torino

Caers J; Fernández de Larrea C; Leleu X; Heusschen R; Zojer N; Decaux O; Kastritis E; Minnema M; Jurczyszyn A; Beguin Y; Wäsch R; Palumbo A; Dimopoulos M; Mateos MV; Ludwig H; Engelhardt M;

Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM. in Blood / Blood. 2016 Jun 9;127(23):2833-40. doi: 10.1182/blood-2016-01-694604. Epub 2016 Apr 18.
2016
AOU Città della Salute di Torino

Jakubowiak A; Offidani M; Pégourie B; De La Rubia J; Garderet L; Laribi K; Bosi A; Marasca R; Laubach J; Mohrbacher A; Carella AM; Singhal AK; Tsao LC; Lynch M; Bleickardt E; Jou YM; Robbins M; Palumbo A;

A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma. in Leukemia / Leukemia. 2016 Jun;30(6):1320-6. doi: 10.1038/leu.2016.36. Epub 2016 Feb 22.
2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Sonneveld P; Offidani M; Boccadoro M; Musolino C; De Paoli L; Conticello C; Nozzoli C; Aghemo E; Derudas D; Genuardi M; Guglielmelli T; Carella AM; Ponticelli E; Spada S; Vincelli ID; De Rosa L; Omedé P; Morabito F; Montefusco V; Passera R; Benevolo G; Liberati AM; Falcone AP; Caravita T; Villani O; Oliva S; Petrucci MT; Bringhen S; et alii...

Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents. in Cytometry. Part B, Clinical cytometry / Cytometry B Clin Cytom. 2016 Jan;90(1):81-90. doi: 10.1002/cyto.b.21279. Epub 2015 Sep 23.
2016
AOU Città della Salute di Torino

Boccadoro M; Palumbo A; Passera R; Marzanati E; Ruggeri M; Astolfi M; Zucchetto A; Gattei V; Gilestro M; Saraci E; Muccio VE; Omedè P;

Advances in targeted therapy for the treatment of patients with relapsed/refractory multiple myeloma. in Expert review of hematology / Expert Rev Hematol. 2016 Jan;9(1):91-105. doi: 10.1586/17474086.2016.1119041.
2016
AOU Città della Salute di Torino

Le Ray E; Jagannath S; Palumbo A;

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. in The Lancet. Oncology / Lancet Oncol. 2016 Aug;17(8):e328-e346. doi: 10.1016/S1470-2045(16)30206-6.
2016
AOU Città della Salute di Torino

Kumar S; Paiva B; Anderson KC; Durie B; Landgren O; Moreau P; Munshi N; Lonial S; Bladé J; Mateos MV; Dimopoulos M; Kastritis E; Boccadoro M; Orlowski R; Goldschmidt H; Spencer A; Hou J; Chng WJ; Usmani SZ; Zamagni E; Shimizu K; Jagannath S; Johnsen HE; Terpos E; Reiman A; Kyle RA; Sonneveld P; Richardson PG; McCarthy P; et alii...

Moving Toward a Tailored Therapy in Multiple Myeloma. in Journal of oncology practice / J Oncol Pract. 2016 Apr;12(4):293-4. doi: 10.1200/JOP.2016.011627.
2016
AOU Città della Salute di Torino

D'Agostino M; Palumbo A;

Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study. in The Lancet. Haematology / Lancet Haematol. 2016 Apr;3(4):e196-204. doi: 10.1016/S2352-3026(16)00021-1. Epub 2016 Mar 18.
2016
AOU Città della Salute di Torino

Amorim S; Stathis A; Gleeson M; Iyengar S; Magarotto V; Leleu X; Morschhauser F; Karlin L; Broussais F; Rezai K; Herait P; Kahatt C; Lokiec F; Salles G; Facon T; Palumbo A; Cunningham D; Zucca E; Thieblemont C;

New pharmacotherapy options for multiple myeloma. in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2016;17(2):181-92. doi: 10.1517/14656566.2016.1115016. Epub 2015 Dec 18.
2016
AOU Città della Salute di Torino

Palumbo A; Aghemo E; Bernardini A; Cerrato C; Mina R;

Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era begins. in Leukemia & lymphoma / Leuk Lymphoma. 2016;57(3):537-56. doi: 10.3109/10428194.2015.1102245. Epub 2015 Dec 23.
2016
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Bonello F; Salvini M; Magarotto V;

Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2015 Oct 20;33(30):3459-66. doi: 10.1200/JCO.2014.60.2466. Epub 2015 Aug 17.
2015
AOU Città della Salute di Torino

Palumbo A; Gay F; Cavallo F; Di Raimondo F; Larocca A; Hardan I; Nagler A; Petrucci MT; Hajek R; Pezzatti S; Delforge M; Patriarca F; Donato F; Cerrato C; Nozzoli C; Yu Z; Boccadifuoco L; Caravita T; Benevolo G; Guglielmelli T; Vincelli D; Jacques C; Dimopoulos MA; Ciccone G; Musto P; Corradini P; Cavo M; Boccadoro M;

Autologous Transplantation in Elderly Multiple Myeloma Patients: Is the Procedure Cost Effective? in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2015 Oct;21(10):1705-6. doi: 10.1016/j.bbmt.2015.08.005. Epub 2015 Aug
2015
AOU Città della Salute di Torino

Gay F; Palumbo A;

How I treat fragile myeloma patients. in Blood / Blood. 2015 Nov 5;126(19):2179-85. doi: 10.1182/blood-2015-05-612960. Epub 2015 Aug 31.
2015
AOU Città della Salute di Torino

Larocca A; Palumbo A;

Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factors. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Nov;26(11):2247-56. doi: 10.1093/annonc/mdv325. Epub 2015 Jul 27.
2015
AOU Città della Salute di Torino

Dimopoulos MA; Sonneveld P; Siegel D; Palumbo A; San-Miguel J;

Anergic bone marrow V?9V?2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma. in Oncoimmunology / Oncoimmunology. 2015 May 26;4(11):e1047580. doi: 10.1080/2162402X.2015.1047580. eCollection 2015 Nov
2015
AOU Città della Salute di Torino

Castella B; Foglietta M; Sciancalepore P; Rigoni M; Coscia M; Griggio V; Vitale C; Ferracini R; Saraci E; Omedé P; Riganti C; Palumbo A; Boccadoro M; Massaia M;

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR. in The Journal of molecular diagnostics : JMD / J Mol Diagn. 2015 Nov;17(6):652-60. doi: 10.1016/j.jmoldx.2015.05.007. Epub 2015 Aug 28.
2015
AOU Città della Salute di Torino

Drandi D; Kubiczkova-Besse L; Ferrero S; Dani N; Passera R; Mantoan B; Gambella M; Monitillo L; Saraci E; Ghione P; Genuardi E; Barbero D; Omedè P; Barberio D; Hajek R; Vitolo U; Palumbo A; Cortelazzo S; Boccadoro M; Inghirami G; Ladetto M;

Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation. in Bone marrow transplantation / Bone Marrow Transplant. 2015 May;50(5):673-8. doi: 10.1038/bmt.2014.322. Epub 2015 Feb 2.
2015
AOU Città della Salute di Torino

Brioli A; Perrone G; Patriarca F; Pezzi A; Nobile F; Ballerini F; Motta MR; Ronconi S; Tacchetti P; Catalano L; Zannetti BA; Rizzi S; Volpe S; Zamagni E; Liberati AM; Mancuso K; Boccadoro M; Davies FE; Morgan GJ; Palumbo A; Cavo M;

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. in Blood / Blood. 2015 Mar 26;125(13):2068-74. doi: 10.1182/blood-2014-12-615187. Epub 2015 Jan 27.
2015
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Mateos MV; Larocca A; Facon T; Kumar SK; Offidani M; McCarthy P; Evangelista A; Lonial S; Zweegman S; Musto P; Terpos E; Belch A; Hajek R; Ludwig H; Stewart AK; Moreau P; Anderson K; Einsele H; Durie BG; Dimopoulos MA; Landgren O; San Miguel JF; Richardson P; Sonneveld P; Rajkumar SV;

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival. in Leukemia / Leukemia. 2015 Mar;29(3):689-95. doi: 10.1038/leu.2014.219. Epub 2014 Jul 16.
2015
AOU Città della Salute di Torino

Terragna C; Musto P; Oliva S; Pisani F; Falcone AP; Pregno P; Crippa C; De Rosa L; Callea V; Carovita T; Liberati AM; Cangialosi C; Guglielmelli T; Rossini F; Grasso M; Caltagirone S; Urbano M; Genuardi E; Cavallo F; Ladetto M; Drandi D; Ferrero S; Passera R; Boccadoro M; Palumbo A;

Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma. in Blood / Blood. 2015 Jan 15;125(3):449-56. doi: 10.1182/blood-2014-05-576256. Epub 2014 Nov 14.
2015
AOU Città della Salute di Torino

Palumbo A; Lonergan S; de Weerdt O; Broyl A; van Marwijk-Kooy M; Vellenga E; Kersten MJ; van der Holt B; Asselbergs E; Zweegman S; Sonneveld P; Lokhorst H;

2015
AOU Città della Salute di Torino

Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A;

Immunotherapy: the next step in the treatment of myeloma. in The Lancet. Haematology / Lancet Haematol. 2015 Dec;2(12):e504-5. doi: 10.1016/S2352-3026(15)00226-4. Epub 2015 Nov 16.
2015
AOU Città della Salute di Torino

Palumbo A;

2015
AOU Città della Salute di Torino

Musto P; Simeon V; Grossi A; Gay F; Bringhen S; Larocca A; Guariglia R; Pietrantuono G; Villani O; D'Arena G; Cuomo C; Musto C; Morabito F; Petrucci MT; Offidani M; Zamagni E; Tacchetti P; Conticello C; Milone G; Palumbo A; Cavo M; Boccadoro M;

MET/HGF pathway in multiple myeloma: from diagnosis to targeted therapy? in Expert review of molecular diagnostics / Expert Rev Mol Diagn. 2015;15(7):881-93. doi: 10.1586/14737159.2015.1046436. Epub 2015 May 12.
2015
AOU Città della Salute di Torino

Gambella M; Palumbo A; Rocci A;

Autologous transplantation and maintenance therapy in multiple myeloma. in The New England journal of medicine / N Engl J Med. 2014 Sep 4;371(10):895-905. doi: 10.1056/NEJMoa1402888.
2014
AOU Città della Salute di Torino

Palumbo A; Cavallo F; Gay F; Di Raimondo F; Ben Yehuda D; Petrucci MT; Pezzatti S; Caravita T; Cerrato C; Ribakovsky E; Genuardi M; Cafro A; Marcatti M; Catalano L; Offidani M; Carella AM; Zamagni E; Patriarca F; Musto P; Evangelista A; Ciccone G; Omedé P; Crippa C; Corradini P; Nagler A; Boccadoro M; Cavo M;

Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2014 Sep;23(9):1193-209. doi: 10.1517/13543784.2014.920821. Epub 2014 Ju
2014
AOU Città della Salute di Torino

Bringhen S; Gay F; Donato F; Troia R; Mina R; Palumbo A;

Circulating miRNA markers show promise as new prognosticators for multiple myeloma. in Leukemia / Leukemia. 2014 Sep;28(9):1922-6. doi: 10.1038/leu.2014.155. Epub 2014 May 12.
2014
AOU Città della Salute di Torino

Rocci A; Hofmeister CC; Geyer S; Stiff A; Gambella M; Cascione L; Guan J; Benson DM; Efebera YA; Talabere T; Dirisala V; Smith EM; Omedè P; Isaia G; De Luca L; Rossi D; Gentili S; Uccello G; Consiglio J; Ria R; Benevolo G; Bringhen S; Callea V; Weiss B; Ferro A; Magarotto V; Alder H; Byrd JC; Boccadoro M; et alii...

Maintenance therapy for multiple myeloma. in Hematology/oncology clinics of North America / Hematol Oncol Clin North Am. 2014 Oct;28(5):839-59. doi: 10.1016/j.hoc.2014.06.006. Epub 2014 Jul 22
2014
AOU Città della Salute di Torino

McCarthy PL; Palumbo A;

The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status. in Haematologica / Haematologica. 2014 Oct;99(10):1605-10. doi: 10.3324/haematol.2014.105866. Epub 2014 Jun 27.
2014
AOU Città della Salute di Torino

Foglietta M; Castella B; Mariani S; Coscia M; Godio L; Ferracini R; Ruggeri M; Muccio V; Omedé P; Palumbo A; Boccadoro M; Massaia M;

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies. in Haematologica / Haematologica. 2014 Oct;99(10):1611-7. doi: 10.3324/haematol.2014.103853. Epub 2014 Jul 11.
2014
AOU Città della Salute di Torino

Caltagirone S; Ruggeri M; Aschero S; Gilestro M; Oddolo D; Gay F; Bringhen S; Musolino C; Baldini L; Musto P; Petrucci MT; Gaidano G; Passera R; Bruno B; Palumbo A; Boccadoro M; Omedè P;

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. in The Lancet. Oncology / Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.
2014
AOU Città della Salute di Torino

Rajkumar SV; Dimopoulos MA; Palumbo A; Blade J; Merlini G; Mateos MV; Kumar S; Hillengass J; Kastritis E; Richardson P; Landgren O; Paiva B; Dispenzieri A; Weiss B; LeLeu X; Zweegman S; Lonial S; Rosinol L; Zamagni E; Jagannath S; Sezer O; Kristinsson SY; Caers J; Usmani SZ; Lahuerta JJ; Johnsen HE; Beksac M; Cavo M; Goldschmidt H; et alii...

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Mar 1;32(7):634-40. doi: 10.1200/JCO.2013.52.0023. Epub 2014 Jan 21.
2014
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ria R; Offidani M; Gaidano G; Passera R; Nozzoli C; Guglielmelli T; Mina R; Morabito F; Marasca R; Omedé P; Bringhen S; Larocca A; Rossi D; Di Raimondo F; Magarotto V; Patriarca F; Levi A; Benevolo G; Vincelli ID; Grasso M; Franceschini L; Gottardi D; Zambello R; Montefusco V; Falcone AP; Palumbo A; Petrucci MT; Musto P; Boccadoro M; et alii...

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients. in British journal of haematology / Br J Haematol. 2014 Mar;164(6):841-50. doi: 10.1111/bjh.12719. Epub 2014 Jan 23.
2014
AOU Città della Salute di Torino

Rocci A; Gambella M; Aschero S; Baldi I; Trusolino L; Cavallo F; Gay F; Larocca A; Magarotto V; Omedè P; Isaia G; Bertotti A; Liberati AM; Catalano L; De Rosa L; Musto P; Vallone R; Falcone A; Drandi D; Ladetto M; Comoglio PM; Boccadoro M; Palumbo A;

Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data. in The Lancet. Oncology / Lancet Oncol. 2014 Mar;15(3):333-42. doi: 10.1016/S1470-2045(13)70609-0. Epub 2014 Feb 11.
2014
AOU Città della Salute di Torino

Palumbo A; Bringhen S; Kumar SK; Lupparelli G; Usmani S; Waage A; Larocca A; van der Holt B; Musto P; Offidani M; Petrucci MT; Evangelista A; Zweegman S; Nooka AK; Spencer A; Dimopoulos MA; Hajek R; Cavo M; Richardson P; Lonial S; Ciccone G; Boccadoro M; Anderson K; Barlogie B; Sonneveld P; McCarthy PL;

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network. in Haematologica / Haematologica. 2014 Jun;99(6):984-96. doi: 10.3324/haematol.2013.100552. Epub 2014 Mar 21.
2014
AOU Città della Salute di Torino

van de Donk NW; Palumbo A; Johnsen HE; Engelhardt M; Gay F; Gregersen H; Hajek R; Kleber M; Ludwig H; Morgan G; Musto P; Plesner T; Sezer O; Terpos E; Waage A; Zweegman S; Einsele H; Sonneveld P; Lokhorst HM;

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. in Leukemia / Leukemia. 2014 Jun;28(6):1299-307. doi: 10.1038/leu.2013.375. Epub 2013 Dec 17.
2014
AOU Città della Salute di Torino

Ladetto M; Brüggemann M; Monitillo L; Ferrero S; Pepin F; Drandi D; Barbero D; Palumbo A; Passera R; Boccadoro M; Ritgen M; Gökbuget N; Zheng J; Carlton V; Trautmann H; Faham M; Pott C;

Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study. in Blood / Blood. 2014 Jul 3;124(1):63-9. doi: 10.1182/blood-2014-03-563759. Epub 2014 May 22.
2014
AOU Città della Salute di Torino
AOU Novara

Boccadoro M; Caravita T; Tacchetti P; Oliva S; Montefusco V; Genuardi M; Benevolo G; Ciccone G; Gentilini F; Offidani M; Omedé P; Boccadifuoco L; Musto P; Magarotto V; Rossi D; Conticello C; Larocca A; Petrucci MT; Bringhen S; Sonneveld P; Palumbo A;

Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia. in Leukemia / Leukemia. 2014 Jan;28(1):222-5. doi: 10.1038/leu.2013.241. Epub 2013 Aug 20.
2014
AOU Città della Salute di Torino

Musto P; Simeon V; Martorelli MC; Petrucci MT; Cascavilla N; Di Raimondo F; Caravita T; Morabito F; Offidani M; Olivieri A; Benevolo G; Mina R; Guariglia R; D'Arena G; Mansueto G; Filardi N; Nobile F; Levi A; Falcone A; Cavalli M; Pietrantuono G; Villani O; Bringhen S; Omedè P; Lerose R; Agnelli L; Todoerti K; Neri A; Boccadoro M; et alii...

Optimal management of elderly patients with myeloma. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2014 Feb;14(2):217-28. doi: 10.1586/14737140.2014.856269. Epub 2013 Dec
2014
AOU Città della Salute di Torino

Cerrato C; Mina R; Palumbo A;

Monoclonal antibodies currently in Phase II and III trials for multiple myeloma. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2014 Aug;14(8):1127-44. doi: 10.1517/14712598.2014.908848. Epub 2014 Apr 21.
2014
AOU Città della Salute di Torino

Donato F; Gay F; Bringhen S; Troia R; Palumbo A;

Pharmacophore modeling technique applied for the discovery of proteasome inhibitors. in Expert opinion on drug discovery / Expert Opin Drug Discov. 2014 Aug;9(8):931-43. doi: 10.1517/17460441.2014.923838. Epub 2014 May 30.
2014
AOU Città della Salute di Torino

Pautasso C; Troia R; Genuardi M; Palumbo A;

Role of consolidation/maintenance therapy in multiple myeloma. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2013 Sep;13 Suppl 2:S349-54. doi: 10.1016/j.clml.2013.05.009.
2013
AOU Città della Salute di Torino

Palumbo A; Mina R; Cerrato C; Cavallo F;

The impact of response on bone-directed therapy in patients with multiple myeloma. in Blood / Blood. 2013 Oct 24;122(17):2974-7. doi: 10.1182/blood-2013-04-498139. Epub 2013 Aug 23.
2013
AOU Città della Salute di Torino

Larocca A; Child JA; Cook G; Jackson GH; Russell N; Szubert A; Gregory WM; Brioli A; Owen RG; Drayson MT; Wu P; Palumbo A; Boccadoro M; Davies FE; Morgan GJ;

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. in Blood / Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16.
2013
AOU Città della Salute di Torino
ASL Vercelli

Larocca A; Montefusco V; Bringhen S; Rossi D; Crippa C; Mina R; Galli M; Marcatti M; La Verde G; Giuliani N; Magarotto V; Guglielmelli T; Rota-Scalabrini D; Omedé P; Santagostino A; Baldi I; Carella AM; Boccadoro M; Corradini P; Palumbo A;

The mechanism of action, pharmacokinetics, and clinical efficacy of carfilzomib for the treatment of multiple myeloma. in Expert opinion on drug metabolism & toxicology / Expert Opin Drug Metab Toxicol. 2013 Oct;9(10):1371-9. doi: 10.1517/17425255.2013.817556. Epub 2013
2013
AOU Città della Salute di Torino

Pautasso C; Bringhen S; Cerrato C; Magarotto V; Palumbo A;

Diagnosis and therapy of multiple myeloma. in The Korean journal of internal medicine / Korean J Intern Med. 2013 May;28(3):263-73. doi: 10.3904/kjim.2013.28.3.263. Epub 2013 May 1.
2013
AOU Città della Salute di Torino

Palumbo A; Cerrato C;

Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials. in Haematologica / Haematologica. 2013 Jun;98(6):980-7. doi: 10.3324/haematol.2012.075051. Epub 2013 Feb 26.
2013
AOU Città della Salute di Torino

Bringhen S; Mateos MV; Zweegman S; Larocca A; Falcone AP; Oriol A; Rossi D; Cavalli M; Wijermans P; Ria R; Offidani M; Lahuerta JJ; Liberati AM; Mina R; Callea V; Schaafsma M; Cerrato C; Marasca R; Franceschini L; Evangelista A; Teruel AI; van der Holt B; Montefusco V; Ciccone G; Boccadoro M; San Miguel J; Sonneveld P; Palumbo A;

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results. in Blood / Blood. 2013 Aug 22;122(8):1376-83. doi: 10.1182/blood-2013-02-483073. Epub 2013 Jun 17.
2013
AOU Città della Salute di Torino

Gay F; Magarotto V; Crippa C; Pescosta N; Guglielmelli T; Cavallo F; Pezzatti S; Ferrari S; Liberati AM; Oliva S; Patriarca F; Offidani M; Omedé P; Montefusco V; Petrucci MT; Giuliani N; Passera R; Pietrantuono G; Boccadoro M; Corradini P; Palumbo A;